Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance

Biswas, 2010, Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nat Immunol, 11, 889, 10.1038/ni.1937

Mantovani, 2002, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends Immunol, 23, 549, 10.1016/S1471-4906(02)02302-5

Mosser, 2008, Exploring the full spectrum of macrophage activation, Nat Rev Immunol, 8, 958, 10.1038/nri2448

O’Shea, 2010, Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells, Science, 327, 1098, 10.1126/science.1178334

Verreck, 2004, Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria, Proc Natl Acad Sci U S A, 101, 4560, 10.1073/pnas.0400983101

Martinez, 2009, Alternative activation of macrophages: an immunologic functional perspective, Annu Rev Immunol, 27, 451, 10.1146/annurev.immunol.021908.132532

Gordon, 2010, Alternative activation of macrophages: mechanism and functions, Immunity, 32, 593, 10.1016/j.immuni.2010.05.007

Mills, 2012, M1 and M2 macrophages: oracles of health and disease, Crit Rev Immunol, 32, 463, 10.1615/CritRevImmunol.v32.i6.10

Sica, 2012, Macrophage plasticity and polarization: in vivo veritas, J Clin Invest, 122, 787, 10.1172/JCI59643

Mosser, 2003, The many faces of macrophage activation, J Leukoc Biol, 73, 209, 10.1189/jlb.0602325

Raes, 2005, Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells, J Immunol, 174, 6561, 10.4049/jimmunol.174.11.6561

Gordon, 2005, Monocyte and macrophage heterogeneity, Nat Rev Immunol, 5, 953, 10.1038/nri1733

Mantovani, 2011, Cancer-promoting tumor-associated macrophages: new vistas and open questions, Eur J Immunol, 41, 2522, 10.1002/eji.201141894

Biswas, 2012, Orchestration of metabolism by macrophages, Cell Metab, 15, 432, 10.1016/j.cmet.2011.11.013

Biswas, 2012, Macrophage polarization and plasticity in health and disease, Immunol Res, 53, 11, 10.1007/s12026-012-8291-9

Labonte, 2014, The role of macrophage polarization in infectious and inflammatory diseases, Mol Cells, 37, 275, 10.14348/molcells.2014.2374

Mills, 2000, M-1/M-2 macrophages and the Th1/Th2 paradigm, J Immunol, 164, 6166, 10.4049/jimmunol.164.12.6166

Escribese, 2012, Influence of low oxygen tensions on macrophage polarization, Immunobiology, 217, 1233, 10.1016/j.imbio.2012.07.002

Saccani, 2006, p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance, Cancer Res, 66, 11432, 10.1158/0008-5472.CAN-06-1867

Guiducci, 2005, Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection, Cancer Res, 65, 3437, 10.1158/0008-5472.CAN-04-4262

Krausgruber, 2011, IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses, Nat Immunol, 12, 231, 10.1038/ni.1990

Fleetwood, 2009, GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling, J Leukoc Biol, 86, 411, 10.1189/jlb.1108702

Donlin, 2014, Modulation of TNF-Induced Macrophage Polarization by Synovial Fibroblasts, J Immunol, 193, 2373, 10.4049/jimmunol.1400486

Sauer, 2014, Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation, Mol Pain, 10, 10, 10.1186/1744-8069-10-10

Orr, 2012, Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages, Diabetes, 61, 2718, 10.2337/db11-1595

Rothlin, 2007, TAM receptors are pleiotropic inhibitors of the innate immune response, Cell, 131, 1124, 10.1016/j.cell.2007.10.034

Kobayashi, 2002, IRAK-M is a negative regulator of Toll-like receptor signaling, Cell, 110, 191, 10.1016/S0092-8674(02)00827-9

Liew, 2005, Negative regulation of toll-like receptor-mediated immune responses, Nat Rev Immunol, 5, 446, 10.1038/nri1630

Rauh, 2005, SHIP represses the generation of alternatively activated macrophages, Immunity, 23, 361, 10.1016/j.immuni.2005.09.003

Biswas, 2009, Endotoxin tolerance: new mechanisms, molecules and clinical significance, Trends Immunol, 30, 475, 10.1016/j.it.2009.07.009

Whyte, 2011, Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function, J Leukoc Biol, 90, 845, 10.1189/jlb.1110644

Liu, 2008, Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo, J Immunol, 180, 6270, 10.4049/jimmunol.180.9.6270

Narayana, 2008, NOTCH1 up-regulation and signaling involved in Mycobacterium bovis BCG-induced SOCS3 expression in macrophages, J Biol Chem, 283, 12501, 10.1074/jbc.M709960200

Wang, 2010, Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses, Cancer Res, 70, 4840, 10.1158/0008-5472.CAN-10-0269

Qin, 2012, SOCS3 deficiency promotes M1 macrophage polarization and inflammation, J Immunol, 189, 3439, 10.4049/jimmunol.1201168

O’Farrell, 1998, IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways, EMBO J, 17, 1006, 10.1093/emboj/17.4.1006

Lang, 2002, Shaping gene expression in activated and resting primary macrophages by IL-10, J Immunol, 169, 2253, 10.4049/jimmunol.169.5.2253

Nelms, 1999, The IL-4 receptor: signaling mechanisms and biologic functions, Annu Rev Immunol, 17, 701, 10.1146/annurev.immunol.17.1.701

Chawla, 2010, Control of macrophage activation and function by PPARs, Circ Res, 106, 1559, 10.1161/CIRCRESAHA.110.216523

Bouhlel, 2007, PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties, Cell Metab, 6, 137, 10.1016/j.cmet.2007.06.010

Liao, 2011, Kruppel-like factor 4 regulates macrophage polarization, J Clin Invest, 121, 2736, 10.1172/JCI45444

Sharma, 2012, Myeloid Kruppel-like factor 4 deficiency augments atherogenesis in ApoE-/- mice – brief report, Arterioscler Thromb Vasc Biol, 32, 2836, 10.1161/ATVBAHA.112.300471

Babaev, 2005, Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice, Arterioscler Thromb Vasc Biol, 25, 1647, 10.1161/01.ATV.0000173413.31789.1a

Martinez, 2013, Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences, Blood, 121, e57, 10.1182/blood-2012-06-436212

Shirey, 2010, Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent, Mucosal Immunol, 3, 291, 10.1038/mi.2010.6

Luzina, 2012, Regulation of inflammation by interleukin-4: a review of “alternatives.”, J Leukoc Biol, 92, 753, 10.1189/jlb.0412214

Odegaard, 2007, Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance, Nature, 447, 1116, 10.1038/nature05894

Mukundan, 2009, PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance, Nat Med, 15, 1266, 10.1038/nm.2048

Eguchi, 2011, Transcriptional control of adipose lipid handling by IRF4, Cell Metab, 13, 249, 10.1016/j.cmet.2011.02.005

Park-Min, 2005, Regulation of macrophage phenotype by long-term exposure to IL-10, Immunobiology, 210, 77, 10.1016/j.imbio.2005.05.002

Imtiyaz, 2010, Hypoxia-inducible factors as essential regulators of inflammation, Curr Top Microbiol Immunol, 345, 105, 10.1007/82_2010_74

Imtiyaz, 2010, Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation, J Clin Invest, 120, 2699, 10.1172/JCI39506

Bosco, 2006, Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene, J Immunol, 177, 1941, 10.4049/jimmunol.177.3.1941

Fang, 2009, Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia, Blood, 114, 844, 10.1182/blood-2008-12-195941

Murdoch, 2005, Macrophage migration and gene expression in response to tumor hypoxia, Int J Cancer, 117, 701, 10.1002/ijc.21422

Cramer, 2003, HIF-1alpha is essential for myeloid cell-mediated inflammation, Cell, 112, 645, 10.1016/S0092-8674(03)00154-5

Rius, 2008, NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha, Nature, 453, 807, 10.1038/nature06905

Nizet, 2009, Interdependence of hypoxic and innate immune responses, Nat Rev Immunol, 9, 609, 10.1038/nri2607

Colegio, 2014, Functional polarization of tumour-associated macrophages by tumour-derived lactic acid, Nature, 513, 559, 10.1038/nature13490

Tripathi, 2014, Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin, Oncotarget, 5, 5350, 10.18632/oncotarget.2110

Takeda, 2010, Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis, Genes Dev, 24, 491, 10.1101/gad.1881410

Kofler, 2011, Microglia: key innate immune cells of the brain, Toxicol Pathol, 39, 103, 10.1177/0192623310387619

Vandanmagsar, 2011, The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance, Nat Med, 17, 179, 10.1038/nm.2279

Tschopp, 2003, NALPs: a novel protein family involved in inflammation, Nat Rev Mol Cell Biol, 4, 95, 10.1038/nrm1019

Martinon, 2002, The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta, Mol Cell, 10, 417, 10.1016/S1097-2765(02)00599-3

Inohara, 2005, NOD-LRR proteins: role in host-microbial interactions and inflammatory disease, Ann Rev Biochem, 74, 355, 10.1146/annurev.biochem.74.082803.133347

Shaw, 2008, NOD-like receptors (NLRs): bona fide intracellular microbial sensors, Curr Opin Immunol, 20, 377, 10.1016/j.coi.2008.06.001

Chamaillard, 2003, An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid, Nat Immunol, 4, 702, 10.1038/ni945

Girardin, 2003, Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection, J Biol Chem, 278, 8869, 10.1074/jbc.C200651200

Hasegawa, 2008, A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation, EMBO J, 27, 373, 10.1038/sj.emboj.7601962

Hitotsumatsu, 2008, The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals, Immunity, 28, 381, 10.1016/j.immuni.2008.02.002

Keestra, 2013, Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1, Nature, 496, 233, 10.1038/nature12025

Hansen, 2008, The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation, Cell, 134, 496, 10.1016/j.cell.2008.05.053

Lehtonen, 2007, Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells, J Leukoc Biol, 82, 710, 10.1189/jlb.0307194

Beyer, 2012, High-resolution transcriptome of human macrophages, PLoS One, 7, e45466, 10.1371/journal.pone.0045466

Dranoff, 1993, Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity, Proc Natl Acad Sci U S A, 90, 3539, 10.1073/pnas.90.8.3539

Dirksen, 1997, Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression, J Clin Invest, 100, 2211, 10.1172/JCI119758

Dirksen, 1998, Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure, Blood, 92, 1097

Baltimore, 2008, MicroRNAs: new regulators of immune cell development and function, Nat Immunol, 9, 839, 10.1038/ni.f.209

Squadrito, 2013, MicroRNA-mediated control of macrophages and its implications for cancer, Trends Immunol, 34, 350, 10.1016/j.it.2013.02.003

Graff, 2012, Identifying functional microRNAs in macrophages with polarized phenotypes, J Biol Chem, 287, 21816, 10.1074/jbc.M111.327031

O’Connell, 2008, Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder, J Exp Med, 205, 585, 10.1084/jem.20072108

Taganov, 2006, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc Natl Acad Sci U S A, 103, 12481, 10.1073/pnas.0605298103

Barish, 2010, Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response, Genes Dev, 24, 2760, 10.1101/gad.1998010

Tili, 2007, Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock, J Immunol, 179, 5082, 10.4049/jimmunol.179.8.5082

Bazzoni, 2009, Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals, Proc Natl Acad Sci U S A, 106, 5282, 10.1073/pnas.0810909106

Zhu, 2013, MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein alpha, J Allergy Clin Immunol, 132, 426e, 10.1016/j.jaci.2013.02.005

Liu, 2011, MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation, FEBS Lett, 585, 1963, 10.1016/j.febslet.2011.05.029

Sheedy, 2010, Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21, Nat Immunol, 11, 141, 10.1038/ni.1828

Nahid, 2011, Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling, J Immunol, 186, 1723, 10.4049/jimmunol.1002311

Ponomarev, 2011, MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway, Nat Med, 17, 64, 10.1038/nm.2266

Zhuang, 2012, A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation, Circulation, 125, 2892, 10.1161/CIRCULATIONAHA.111.087817

Banerjee, 2013, MicroRNA let-7c regulates macrophage polarization, J Immunol, 190, 6542, 10.4049/jimmunol.1202496

Lu, 2009, Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines, J Immunol, 182, 7212, 10.4049/jimmunol.0802971

Litvak, 2009, Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals, Nat Immunol, 10, 437, 10.1038/ni.1721

Martinez-Nunez, 2011, The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1), J Biol Chem, 286, 1786, 10.1074/jbc.M110.169367

Cai, 2012, Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155, J Mol Cell Biol, 4, 341, 10.1093/jmcb/mjs044

Pedersen, 2009, Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas, EMBO Mol Med., 1, 288, 10.1002/emmm.200900028

Doyle, 2005, Bruton’s tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide, J Biol Chem, 280, 23496, 10.1074/jbc.C500053200

Doyle, 2007, Signaling by Toll-like receptors 8 and 9 requires Bruton’s tyrosine kinase, J Biol Chem, 282, 36953, 10.1074/jbc.M707682200

Horwood, 2003, Bruton’s tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production, J Exp Med, 197, 1603, 10.1084/jem.20021845

Horwood, 2006, Bruton’s tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production, J Immunol, 176, 3635, 10.4049/jimmunol.176.6.3635

Ni Gabhann, 2014, Btk regulates macrophage polarization in response to lipopolysaccharide, PLoS One, 9, e85834, 10.1371/journal.pone.0085834

Lee, 2012, Bruton’s tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response, Proc Natl Acad Sci U S A, 109, 5791, 10.1073/pnas.1119238109

Schlaepfer, 2014, Triggering TLR2, 3, 4, 5 and 8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV, J Virol, 88, 9769, 10.1128/JVI.01053-14

Biswas, 2006, A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation), Blood, 107, 2112, 10.1182/blood-2005-01-0428

Porta, 2009, Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB, Proc Natl Acad Sci U S A, 106, 14978, 10.1073/pnas.0809784106

Garofalo, 2003, Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta, J Clin Invest, 112, 197, 10.1172/JCI16885

Kadl, 2010, Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2, Circ Res, 107, 737, 10.1161/CIRCRESAHA.109.215715

Umemura, 2008, Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics, J Leukoc Biol, 83, 1136, 10.1189/jlb.0907611

Carpenter, 2013, A long noncoding RNA mediates both activation and repression of immune response genes, Science, 341, 789, 10.1126/science.1240925

Li, 2014, The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL, Proc Natl Acad Sci U S A, 111, 1002, 10.1073/pnas.1313768111

Mylonas, 2009, Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing, J Immunol, 182, 3084, 10.4049/jimmunol.0803463

Stout, 2005, Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences, J Immunol, 175, 342, 10.4049/jimmunol.175.1.342

Hyam, 2013, Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages, Eur J Pharmacol, 708, 21, 10.1016/j.ejphar.2013.01.014

Jang, 2013, Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-kappaB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages, J Appl Microbiol, 115, 888, 10.1111/jam.12273